Disruption of the plasminogen activator inhibitor‐1 gene reduces the adiposity and improves the metabolic profile of genetically obese and diabetic ob/ob mice

This publication has 49 references indexed in Scilit:

• Troglitazone Improves Defects in Insulin Action, Insulin Secretion, Ovarian Steroidogenesis, and Fibrinolysis in Women with Polycystic Ovary Syndrome
  Journal of Clinical Endocrinology & Metabolism, 1997
• Polymerase Chain Reaction‐Restriction Fragment Length Polymorphisms (PCR‐RFLP) and Electrophoretic Assays for the Mouse Obese (Lep^ob) Mutation
  Obesity Research, 1997
• Elevation of plasminogen activator inhibitor 1 in borderline hypertension is linked to concomitant metabolic disturbances
  European Journal of Clinical Investigation, 1996
• Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo. Induction by tumor necrosis factor-alpha and lipopolysaccharide.
  Journal of Clinical Investigation, 1996
• Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance.
  Journal of Clinical Investigation, 1995
• The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase.
  Journal of Clinical Investigation, 1995
• Altered gene expression for tumor necrosis factor-alpha and its receptors during drug and dietary modulation of insulin resistance
  Endocrinology, 1994
• Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization.
  Journal of Clinical Investigation, 1993
• Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
  Science, 1993
• In vivo cytokine gene expression in T cell subsets of the autoimmune MRL/Mp‐lpr/lpr mouse
  European Journal of Immunology, 1990